The agency is requiring GLP-1 manufacturers to warn the drugs can increase risk of “eye stroke.”
November 9, 2026 at 3:50 p.m. EST52 minutes ago
(The Washington Post illustration; iStock)
The Food and Drug Administration announced Monday that it is requiringmanufacturers of GLP-1 medications to warn that they can increase the risk of vision loss.
The warning applies to all GLP-1 medications, including popular weight loss drugs like Ozempic and Wegovy.